What does E & A FARMA do?

E & A FARMA is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 16 April 2002, 2 establishments.

What is the address of E & A FARMA?

The registered office of E & A FARMA is located at Lindenberg 16, 3080 Tervuren.

Is E & A FARMA still active?

Yes. According to the CBE (29 October 2026) E & A FARMA is active, legal situation “Normale toestand”, started on 16 April 2002.

Is E & A FARMA registered on Peppol?

Yes, E & A FARMA is registered on the Peppol network with ID 0208:0477349371.

What is the enterprise number of E & A FARMA?

The enterprise number of E & A FARMA is BE0477349371.

When was E & A FARMA founded?

E & A FARMA was founded on 16 April 2002.

Who are the directors of E & A FARMA?

According to the 2026 annual accounts, the directors of E & A FARMA are: Inge Annaert, Johan Eykens, Lies Eykens, Tim Eykens.

Is E & A FARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 April 2002; 5 annual accounts filed, latest fiscal year 2026; 4 directors known from the annual account; 2 establishments in the CBE.

How much profit did E & A FARMA make in 2026?

E & A FARMA posted a profit after taxes of € 37,830 in financial year 2026.

What is the revenue of E & A FARMA?

As a small company, E & A FARMA is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 26,074.

How much does an employee at E & A FARMA earn?

The average wage cost per full-time employee at E & A FARMA was € 67,800 in 2025: staff costs of € 325,293 for 4.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does E & A FARMA have?

According to the 2026 annual accounts, E & A FARMA has 0 full-time equivalents (FTE).

E & A FARMA (Private Limited) - Tervuren - BE0477349371

Dossier E & A FARMA, printed on 29 October 2026 from databakkes.be/en/0477349371/e-a-farma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

E & A FARMA from Tervuren, company number BE0477349371, closed financial year 2026 with a result of € 37,830 after tax. For that financial year E & A FARMA recorded a gross margin of € 26,074 and equity of € 934,317. Compared with financial year 2025, the result moved from € 179,149 to € 37,830. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 20, 2026.

What it is worth Healthy

€ 934,317

▼ 21% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 37,830

▼ 79% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 78,834

▼ 54% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 265,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2026

Full-time equivalents

▼ 4.8 vs 2025

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 22,205

▲ 137% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,815

▼ 89% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 18,210

▼ 80% vs 2025

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 534,962 Gross margin 2023: € 534,962 First fiscal year in the series	€ 534,179 Gross margin 2024: € 534,179 Unchanged (€ 534,962) Unfavourable step	€ 637,103 Gross margin 2025: € 637,103 ▲ 19% vs 2024 (€ 534,179) Favourable step	€ 26,074 Gross margin 2026: € 26,074 ▼ 96% vs 2025 (€ 637,103) Unfavourable step	▼ 96%
Profit after taxes	€ 194,642 Profit after taxes 2023: € 194,642 First fiscal year in the series	€ 195,402 Profit after taxes 2024: € 195,402 Unchanged (€ 194,642) Favourable step	€ 179,149 Profit after taxes 2025: € 179,149 ▼ 8% vs 2024 (€ 195,402) Unfavourable step	€ 37,830 Profit after taxes 2026: € 37,830 ▼ 79% vs 2025 (€ 179,149) Unfavourable step	▼ 79%
Equity	€ 1,259,835 Equity 2023: € 1,259,835 First fiscal year in the series	€ 1,142,060 Equity 2024: € 1,142,060 ▼ 9% vs 2023 (€ 1,259,835) Unfavourable step	€ 1,176,806 Equity 2025: € 1,176,806 ▲ 3% vs 2024 (€ 1,142,060) Favourable step	€ 934,317 Equity 2026: € 934,317 ▼ 21% vs 2025 (€ 1,176,806) Unfavourable step	▼ 21%
Total debts	€ 289,287 Total debts 2023: € 289,287 First fiscal year in the series	€ 410,778 Total debts 2024: € 410,778 ▲ 42% vs 2023 (€ 289,287) Unfavourable step	€ 474,179 Total debts 2025: € 474,179 ▲ 15% vs 2024 (€ 410,778) Unfavourable step	€ 220,885 Total debts 2026: € 220,885 ▼ 53% vs 2025 (€ 474,179) Favourable step	▼ 53%
Cash	€ 171,543 Cash 2023: € 171,543 First fiscal year in the series	€ 165,820 Cash 2024: € 165,820 ▼ 3% vs 2023 (€ 171,543) Unfavourable step	€ 171,318 Cash 2025: € 171,318 ▲ 3% vs 2024 (€ 165,820) Favourable step	€ 78,834 Cash 2026: € 78,834 ▼ 54% vs 2025 (€ 171,318) Unfavourable step	▼ 54%
Land & buildings	€ 388,771 Land & buildings 2023: € 388,771 First fiscal year in the series	€ 371,131 Land & buildings 2024: € 371,131 ▼ 5% vs 2023 (€ 388,771) Unchanged	€ 366,792 Land & buildings 2025: € 366,792 ▼ 1% vs 2024 (€ 371,131) Unchanged	€ 357,459 Land & buildings 2026: € 357,459 ▼ 3% vs 2025 (€ 366,792) Unchanged	▼ 3%
Retained profit	€ 1,241,235 Retained profit 2023: € 1,241,235 First fiscal year in the series	€ 1,123,460 Retained profit 2024: € 1,123,460 ▼ 9% vs 2023 (€ 1,241,235) Unfavourable step	€ 1,158,206 Retained profit 2025: € 1,158,206 ▲ 3% vs 2024 (€ 1,123,460) Favourable step	€ 915,959 Retained profit 2026: € 915,959 ▼ 21% vs 2025 (€ 1,158,206) Unfavourable step	▼ 21%
Dividend	€ 105,852 Dividend 2023: € 105,852 First fiscal year in the series	€ 297,779 Dividend 2024: € 297,779 ▲ 181% vs 2023 (€ 105,852) Unchanged	€ 144,402 Dividend 2025: € 144,402 ▼ 52% vs 2024 (€ 297,779) Unchanged	€ 265,000 Dividend 2026: € 265,000 ▲ 84% vs 2025 (€ 144,402) Unchanged	▲ 84%
Bank debt	€ 45,007 Bank debt 2023: € 45,007 First fiscal year in the series	€ 25,403 Bank debt 2024: € 25,403 ▼ 44% vs 2023 (€ 45,007) Favourable step	€ 33,802 Bank debt 2025: € 33,802 ▲ 33% vs 2024 (€ 25,403) Unfavourable step	€ 0 Bank debt 2026: € 0 ▼ 100% vs 2025 (€ 33,802) Favourable step	▼ 100%
Balance sheet total	€ 1,549,122 Balance sheet total 2023: € 1,549,122 First fiscal year in the series	€ 1,552,838 Balance sheet total 2024: € 1,552,838 Unchanged (€ 1,549,122) Unchanged	€ 1,650,985 Balance sheet total 2025: € 1,650,985 ▲ 6% vs 2024 (€ 1,552,838) Unchanged	€ 1,155,202 Balance sheet total 2026: € 1,155,202 ▼ 30% vs 2025 (€ 1,650,985) Unchanged	▼ 30%
Employees (FTE)	3.4 Employees (FTE) 2023: 3.4 First fiscal year in the series	4 Employees (FTE) 2024: 4 ▲ 0.6 vs 2023 (3.4) Unchanged	4.8 Employees (FTE) 2025: 4.8 ▲ 0.8 vs 2024 (4) Unchanged	0 Employees (FTE) 2026: 0 ▼ 4.8 vs 2025 (4.8) Unchanged	▼ 4.8

Key figures of E & A FARMA, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to E & A FARMA?

What happened at E & A FARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 20, 2026 New annual accounts for financial year 2026: profit of € 37,830 (▼ 79% vs 2025). Source: NBB ↗
2024 Tim Eykens became a director. NBB
Jan 1, 2020 New establishment in Machelen (Brab.). KBO
May 16, 2002 New establishment in Tervuren. KBO
Apr 16, 2002 Start of the company according to the CBE. KBO

In short

From € 194,642 profit in 2023 to € 37,830 profit in 2026.

Paid € 274,005 in corporate taxes since 2023.

Best year ever: 2024, with € 195,402 profit.

On average € 132,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Inge Annaert Johan Eykens Lies Eykens Tim Eykens

APOTHEEK DRIE FONTEINEN

JOIN PHARMA

EA CONSULTANTS

E & A FARMA

Behind E & A FARMA are Inge Annaert, Johan Eykens, Lies Eykens and Tim Eykens. Inge Annaert is also behind APOTHEEK DRIE FONTEINEN, JOIN PHARMA and EA CONSULTANTS. Johan Eykens is also behind APOTHEEK DRIE FONTEINEN and EA CONSULTANTS.

Directors

According to the 2026 annual accounts

Inge Annaert

Director

Also active at: APOTHEEK DRIE FONTEINEN, JOIN PHARMA, EA CONSULTANTS

Johan Eykens

Director

Also active at: APOTHEEK DRIE FONTEINEN, EA CONSULTANTS

Lies Eykens

Director

Tim Eykens

Director

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Lindenberg 16

3080 Tervuren

2.300.395.877

Culliganlaan 5 box 11

1831 Machelen (Brab.)

Active since 1 January 2020

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

JOIN PHARMA same network

€ 21,456 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0477.349.371

VAT number

BE 0477.349.371

Registered office

Lindenberg 16, 3080 Tervuren

Names & denominations

E & A FARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

16 April 2002

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Activiteiten van holdings

Managementactiviteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

E & A FARMA

Financials

What happened to E & A FARMA?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions